Aspira Pathlab & Diagnostics Share Price
96.99+3.99 (+4.29%)
+51.86% past 1 Year
Aspira Pathlab & Diagnostics Limited is solely engaged in the business of running laboratories for carrying out Pathological investigations in various branches of Bio-chemistry, Hematology, Histopathology, Microbiology, Immuno-chemistry, Immunology, Virology,
Corporate filings & documents
Announcements
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Jay Arvind Bhanushali
1 day agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Jay Arvind Bhanushali
1 day agoPursuant to Regulation 36 (1)(b) of SEBI (LODR)2015 The Company has dispatched letter containing weblink of Annual Report for Financial year 2025-26
2 days agoPursuant to Regulation 36 (1)(b) of SEBI (LODR)2015 The Company has dispatched letter containing weblink of Annual Report for Financial year 2025-26
2 days agoNewspaper Publication Post Dispatch of 53rd AGM Notice & Annual Report for the Financial Year 2025-26
2 days agoNewspaper Publication Post Dispatch of 53rd AGM Notice & Annual Report for the Financial Year 2025-26
2 days agoPursuant to the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed copy of the Notice of the 31st AGM and the Annual Report for the financial year 2025-26 including the Audited Financial Statements for the year ended March 31 2026 (Annual Report) being sent by email to those members whose email addresses are registered with the Company/Depository Participant(s)
3 days agoPursuant to the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed copy of the Notice of the 31st AGM and the Annual Report for the financial year 2025-26 including the Audited Financial Statements for the year ended March 31 2026 (Annual Report) being sent by email to those members whose email addresses are registered with the Company/Depository Participant(s)
3 days agoIntimation of Notice of 53rd Annual General Meeting for the Financial Year 2025-26
3 days agoIntimation of Notice of 53rd Annual General Meeting for the Financial Year 2025-26
3 days agoWith reference to subject matter please find the attached Documents
3 days agoWith reference to subject matter please find the attached Documents
3 days agoNewspaper Advertisement - Information Regarding 53rd (Fifty -Three) Annual General Meeting of the company
6 days agoNewspaper Advertisement - Information Regarding 53rd (Fifty -Three) Annual General Meeting of the company
6 days agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Jay Arvind Bhanushali
1 week agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Jay Arvind Bhanushali
1 week agoNewspaper Publication for the Financial Result as on 30 June 2026
3 weeks agoNewspaper Publication for the Financial Result as on 30 June 2026
3 weeks ago1. Board approved the appointment of Mr. Vaibhav Odhekar as Additional Executive Director with immediate Effect.2. Board Approved the regularization of Mr. Vaibhav Odhekar as Executive Director subject to approval of Shareholder in ensuring Annual general Meeting 3. Board Approved the Re- Designation Of Mr. Nikunj Velji Mange from Executive Director to Managing Director subject to approval of Shareholder in ensuring Annual General Meeting 4. Board Approved the Appointment of M/s. Harsh Kholiya & Co Practicing Chartered Accountant as an Internal Auditor for Quarter 2 3 and 4 of Financial Year 2026-27
3 weeks ago1. Board approved the appointment of Mr. Vaibhav Odhekar as Additional Executive Director with immediate Effect.2. Board Approved the regularization of Mr. Vaibhav Odhekar as Executive Director subject to approval of Shareholder in ensuring Annual general Meeting 3. Board Approved the Re- Designation Of Mr. Nikunj Velji Mange from Executive Director to Managing Director subject to approval of Shareholder in ensuring Annual General Meeting 4. Board Approved the Appointment of M/s. Harsh Kholiya & Co Practicing Chartered Accountant as an Internal Auditor for Quarter 2 3 and 4 of Financial Year 2026-27
3 weeks agoUnaudited Standalone Financial Results for quarter ended 30 June 2026
3 weeks agoUnaudited Standalone Financial Results for quarter ended 30 June 2026
3 weeks agoOutcome of Board Meeting held on 12th August 2026
3 weeks agoOutcome of Board Meeting held on 12th August 2026
3 weeks agoAspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve 1.Unaudited Financial Result(Standalone) along with Limited Review Report for the First Quarter ended June 30 2026 To consider evaluate and if deem fit to approve the proposal for raising of funds by way of issuance via various mode and to transact Other Businesses.
4 weeks agoAspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve 1.Unaudited Financial Result(Standalone) along with Limited Review Report for the First Quarter ended June 30 2026 To consider evaluate and if deem fit to approve the proposal for raising of funds by way of issuance via various mode and to transact Other Businesses.
4 weeks agoEnclosed herewith Resignation of M/s Vishal J Bhanushali and Associated with effect from 13th August 2026
1 month agoEnclosed herewith Resignation of M/s Vishal J Bhanushali and Associated with effect from 13th August 2026
1 month agoEnclosed herewith Resignation of Mr. Pankaj Jashwant Shah from post of Managing Director and Chief Executive Officer with effect from 03.08.2026
1 month agoEnclosed herewith Resignation of Mr. Pankaj Jashwant Shah from post of Managing Director and Chief Executive Officer with effect from 03.08.2026
1 month agoEnclosed herewith Resignation of Mr. Pankaj Jashwant Shah from post of Managing Director cum Chief Executive Officer with effect from 03.08.2026
1 month agoEnclosed herewith Resignation of Mr. Pankaj Jashwant Shah from post of Managing Director cum Chief Executive Officer with effect from 03.08.2026
1 month agoEnclosed herewith Resignation of Pankaj jashwant Shah (DIN:02836324)
1 month agoEnclosed herewith Resignation of Pankaj jashwant Shah (DIN:02836324)
1 month agoMr. Vaibhav Odhekar has resigned from Company as an Additional Executive Director with effect from close of business hours 25.07.2026
1 month agoMr. Vaibhav Odhekar has resigned from Company as an Additional Executive Director with effect from close of business hours 25.07.2026
1 month agoResignation of Mr. Vaibhav Odhekar as an Additional Executive Director from Company with effect from close of business hours on 25.07.2026
1 month agoResignation of Mr. Vaibhav Odhekar as an Additional Executive Director from Company with effect from close of business hours on 25.07.2026
1 month agoCompliance Certificate in accordance with regulation 74(5) of SEBI (DP) regulation 2018 for quarter ended 30th June 2026
1 month agoCompliance Certificate in accordance with regulation 74(5) of SEBI (DP) regulation 2018 for quarter ended 30th June 2026
1 month agoIntimation of closure of Trading window for quarter ended 30.06.2026
2 months agoIntimation of closure of Trading window for quarter ended 30.06.2026
2 months agoIntimation of Classification of Mr. Nikunj Mange and Mr. Jay Arvind Bhanushali as Promoters of the Company Pursuant to Completion of Open Offer
2 months agoIntimation of Classification of Mr. Nikunj Mange and Mr. Jay Arvind Bhanushali as Promoters of the Company Pursuant to Completion of Open Offer
2 months agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Shraddha Bhanushali & PACs
2 months agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Deepali Arvind Bhanushali & PACs
2 months agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Deepali Arvind Bhanushali & PACs
2 months agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Raj Arvind Bhanushali & PACs
2 months agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Raj Arvind Bhanushali & PACs
2 months agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Jay Arvind Bhanushali & PACs
2 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
No data available.
Company details
Registered office
Flat No. 2, R D Shah Building Shraddanand Road, Opp. Ghatkopar Railway Station Ghatkopar (West) Mumbai Maharashtra PIN: 400086 Tel No: 022-71975756 / 5656 Fax No: NULL Email: [email protected] / [email protected] Internet: www.aspiradiagnostics.com
Registrars
C 101, 247 Park, L B S Marg, Vikhroli (West), Mumbai 400 083.Tel: 2851 5606/ 2851 5644 Fax: 2851 2885E-mail: [email protected] C 101, 247 Park L B S Marg Vikhroli (West) PIN: Tel No: 2851 5606/ 2851 5644 Fax No: 2851 2885 Email: [email protected] Internet: https://in.mpms.mufg.com/
Management
Haseeb A Drabu, Chairman
Mangala R Prabhu, Non Executive Independent Director
Manas Mengar, Non Executive Independent Director
Nikunj Mange, Executive Director
Kiran Raghavendra Awasthi, Non Executive Independent Director
Neetu Maurya, Company Secretary and Compliance Officer
Details
BSE 540788
NSE NULL
ISIN INE500C01017